Wren Capital
Venture capitalLondon · Seed–Series A
What they invest in
from 7 of 8 portfolio companiesDeep Tech ×4Biotech ×3Hardware ×3Medical Devices ×2Semiconductors ×2AdTech ×1Advanced Manufacturing ×1AI & Machine Learning ×1
HQs:United Kingdom×3
Investments · 8 tracked
founders shown can be your intro path
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)in
Co-investorsO2h VenturesWellcome TrustCambridge Angels groupEMV CapitalMartlet CapitalStoic VC+1 more
Keit is a technology hardware company founded in 2013 as a spin-out from the Science and Technology Facilities Council and European Space Agency Business Incubation Centre, developing new technology for established industries.
Advanced ManufacturingDeep TechHardwareOxfordshire, GB
Co-investorsUK Innovation & Science Seed FundFuture Planet Capital
Blu Wireless develops millimeter wave radio networking technology for wireless communications.
Deep TechDefense TechHardwareSemiconductorsBristol, GB
Anthony Murray(Chief Executive Officer)inJohnny Bray(Chief Financial Officer)inDave Purle(Chief Operating Officer)Ciara Barron(Director of Marketing)inDarren McNamara(Director of Technology Development)inJonathan Rogers(Director of Systems and Platforms)in
Co-investorsMaven Capital PartnersCambridge Angels groupSalica InvestmentsARMCalculus Capital Ltd.
Bristol-based developer of mmWave wireless communication systems for defence, high-speed rail and other mobility markets.
Co-investorsCalculus Capital Ltd.Guinness VenturesPerscitus LLP
MitoRx is a preclinical-stage biotech developing MTRX31, a first-in-class small molecule that restores mitochondrial metabolism to eliminate ectopic fat in patients with metabolically unhealthy, high-risk obesity.
BiotechLongevity
Jon R.(Founder)in
Co-investorsFuture Planet CapitalOxford Investment Opportunity Network (OION)Oxford Technology ManagementUK Innovation & Science Seed Fund
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesO2h VenturesParkwalk Advisors
Singular provides a marketing analytics platform that combines cost aggregation, mobile and cross-device attribution, fraud prevention, and creative analytics for marketing teams.
AdTechMarketing TechSaaS
Gadi Eliashiv(CEO & Co-founder)inSusan Kuo(COO & Co-founder)inEran Friedman(CTO & Co-founder)inStephanie Pilon(CMO)inYoni Amias(CCO)inNeil Mills(CRO)in
Co-investorsNorwest Venture PartnersTitanium VenturesTransLink CapitalMethod CapitalZ Venture CapitalACF Investors+4 more
Singular Photonics develops digital image sensors based on single-photon avalanche diode (SPAD) technology, which convert photons directly into digital signals to capture depth and temporal data as 4D images.
Deep TechHardwareMedical DevicesSemiconductors
Co-investorsCambridge Angels groupACF InvestorsOld College CapitalScottish Enterprise
Portfolio news
latest coverage across their companies
Singular Photonics · healthcaretoday.com · Sep 4, 2026
Singular · venturedailydigest.com · Aug 20, 2026
MitoRx Therapeutics · globenewswire.com · Jun 9, 2026
Principals & officers · per Companies House
what is this? ⓘLLP designated member · since 2011
LLP designated member · since 2011
Rajat Malhotra — 25–50% of voting rights, significant influence or control limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership
Richard Donald Cameron — 25–50% of voting rights, significant influence or control limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership
Frequently asked questions
- What stage does Wren Capital invest at?
- Wren Capital invests at the Seed, Series A stages.
- What sectors does Wren Capital focus on?
- Wren Capital focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is Wren Capital located?
- Wren Capital is headquartered in London, GB.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.
Nesta describes itself through its strategy focused on three missions: giving every child a fairer start, helping people live healthy lives, and building a sustainable future.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
Skolkovo Foundation is a Russian innovation ecosystem supporting startups from idea to successful business through grants, investment reimbursement, and infrastructure.